| Paul R. Edick |
Paul R. Edick founded GANIC Pharmaceuticals, Inc. in 2008, where he worked as Chief Executive Officer in 2010. Mr. Edick also currently works at Xeris Biopharma Holdings, Inc., as Chairman & Chief Executive Officer from 2021. Mr. Edick also formerly worked at Xeris Pharmaceuticals, Inc., as Chairman, President & Chief Executive Officer from 2017 to 2020, MedPointe, Inc., as President & Chief Executive Officer from 2002 to 2008, MedPointe Healthcare, Inc., as Chief Executive Officer from 2006 to 2008, Durata Therapeutics, Inc., as President, Chief Executive Officer & Director from 2012 to 2014, Veloxis Pharmaceuticals A, as Chairman from 2009 to 2011, Milestone Pharmaceuticals, Inc., as Chairman, Life Cycle Pharma A, as Chairman in 2011, Iterum Therapeutics Plc, as Chairman from 2015 to 2019, NewLink Genetics Corp., as Independent Director from 2011 to 2018, Informed Medical Communications, Inc., as Director from 2006 to 2011, Circassia Ltd., as Non-Executive Director in 2013, Neos Therapeutics, Inc., as Independent Director from 2015 to 2018, Sucampo Pharmaceuticals LLC, as Independent Director, PDL BioPharma, Inc., as Independent Director from 2015 to 2018, Amerita, Inc., as Director, Niox Group Plc, as Independent Non-Executive Director from 2013 to 2016, Baxter Healthcare Corp., as Principal from 1978 to 1990, Procter & Gamble Co., as Sales Representative from 1977 to 1978, Vicuron Pharmaceuticals LLC, as President, G.D. Searle & Co., Inc., as President-Asia Pacific, Canada & Latin America in 2002, Pharmacia Corp., as VP, President-Asia Pacific & Latin America, MedPointe Capital Partners LLC, as President, 3G Advisors LLC, as Founding Partner, and Searle Pharmaceuticals Pvt Ltd., as President-Asia Pacific, Canada & Latin America. Mr. Edick received his undergraduate degree from Hamilton College (New York). |
| Steven M. Pieper |
Steven M. Pieper is currently the Chief Financial Officer at Xeris Biopharma Holdings, Inc. He previously worked as a Finance Director at Durata Therapeutics, Inc., and as the Chief Financial & Accounting Officer at Xeris Pharmaceuticals, Inc. He also served as the Chief Operating & Financial Officer at Catheter Connections, Inc. from 2015 to 2017. Mr. Pieper received his undergraduate degree from DePaul University and his MBA from Loyola University of Chicago. |
| Kevin McCulloch |
Kevin McCulloch is currently the Chief Commercial Officer at Xeris Biopharma Holdings, Inc. He previously worked as the President-Global Services & Fluid Systems at Baxter Healthcare Corp. from 2004 to 2016. He also held the position of Vice President-Global Marketing at Baxter International, Inc. Additionally, he served as the President-Global Solutions at Hill-Rom Holdings, Inc. from 2017 to 2018. Mr. McCulloch was the SVP-Global Operations & Business Development at Xeris Pharmaceuticals, Inc. and the Chief Business Officer at Water Street Healthcare Partners LLC from 2016 to 2017. He completed his undergraduate degree at the University of Michigan and holds an MBA from the Kellogg School of Management. |
| Ken Johnson |
Ken Johnson is currently the Senior VP-Medical Affairs & Global Development at Xeris Biopharma Holdings, Inc. He previously worked as the Executive Director-US Medical Affairs at Merck & Co., Inc. from 2016 to 2017, and as the Vice President-Analytics & Outcomes Research at Caremark Rx, Inc. from 2000 to 2002. He also held the position of SVP-Clinical Development & Regulatory Affairs at Xeris Pharmaceuticals, Inc. and Vice President-Analytics & Outcomes Research at Caremark LLC. From 2012 to 2015, he was the Vice President-Medical Affairs & Outcomes Research at Durata Therapeutics, Inc. and at Horizon Pharma, Inc. he held the position of Vice President-Medical Affairs & Outcomes Research. He was also the Vice President-Medical Affairs & Outcomes Research at Circassia Pharmaceuticals, Inc. from 2015 to 2016. Dr. Johnson received his doctorate degree from the University of Minnesota in 1987. |
| Steven Prestrelski |
Steven Prestrelski is the founder of Xeris Pharmaceuticals, Inc. (founded in 2005) and Xeris Biopharma Holdings, Inc. (founded in 2005) where he held the title of Chief Scientific Officer. He also held former positions as Executive Director at BaroFold, Inc., VP-Pharmaceutical Research & Development at Amylin Pharmaceuticals, Inc. (from 2005 to 2011), and Vice President-Biopharmaceuticals at Powderject Technologies, Inc. (from 1998 to 2002). Dr. Prestrelski earned a doctorate degree from City University of New York in 1990 and an MBA degree from Rady School of Management at UC San Diego in 2006. |
| John Patrick Shannon |
John Patrick Shannon's current job is President & Chief Operating Officer at Xeris Biopharma Holdings, Inc. His former jobs include being Chief Executive Officer & Director at Catheter Connections, Inc., Executive Director-Cardiovascular Global at Viatris Holdings LLC, GM-Global Hemophilia & Commercial Excellence at Baxter Healthcare Corp., President & Chief Operating Officer at Xeris Pharmaceuticals, Inc., Head-Sales Operations, Marketing & Strategic at Bock Pharmacal Co., Vice President & General Manager at Baxter BioScience Corp., Vice President-Marketing at Caremark LLC, and Chief Commercial Officer at Durata Therapeutics, Inc. He obtained his undergraduate degree from Western Illinois University. |
| Garheng Kong |
Garheng Kong founded Healthquest Capital Management Co LLC in 2012, where he is working as Managing Partner from 2012. Dr. Kong also currently works at Ajax Health LLC, as Chairman of the Board from 2019, Laboratory Corp. of America Holdings, as Independent Director from 2013, Magnolia Medical Technologies, Inc., as Director, and various other companies. Dr. Kong also formerly worked at Serenex, Inc., as Chairman of the Board from 2002 to 2008, Viamet Pharmaceuticals, Inc., as Chairman of the Board from 2005 to 2010, Histogenics Corp., as Chairman from 2012 to 2019, and various other companies. Dr. Kong received his graduate degree, Masters Business Admin degree, and doctorate degree from Duke University and undergraduate degree from Stanford University. |
| Ricki L Fairley |
Ricki L Fairley founded Touch The Black Breast Cancer Alliance, where she worked as Chief Executive Officer. Ms. Fairley also currently works at Triple Negative Breast Cancer Foundation, Inc., as Director and Xeris Biopharma Holdings, Inc., as Independent Director from 2023. Ms. Fairley also formerly worked at Center for Healthcare Innovation, as Director, PowerPact LLC, as Partner & Strategist from 2000 to 2003, IMAGES USA, Inc., as Chief Marketing Officer & Partner from 2009 to 2012, and Perfetti Van Melle USA, Inc., as Vice President-Marketing from 2000 to 2003. Ms. Fairley received her undergraduate degree from Dartmouth College and Masters Business Admin degree from Kellogg School of Management. |
